Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03506997
Title Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (PERSEUS1)
Acronym PERSEUS1
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Institute of Cancer Research, United Kingdom
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR

Additional content available in CKB BOOST